BofA downgrades Amrize to underperform, cuts price target on slower growth outlook
Bank of America downgraded Amrize to Underperform, cutting its price target to $40 from $50 due to slower earnings growth, market risks, and valuation concerns. The brokerage lowered its 2027-28 adjusted EBITDA and EPS estimates, citing stable U.S. cement prices, Canadian demand pressure from U.S. tariffs, and vulnerable roofing margins. BofA forecasts adjusted EBITDA growth of 3% and adjusted EPS growth of 6% annually over 2026-28, excluding large acquisitions. The bank also trimmed its buildin
How this was made
The 30-second read
Why it matters
The downgrade is likely to trigger short‑term selling pressure, but the company's solid balance sheet may support a rebound if acquisition opportunities arise.
Market read
Analyst downgrade with a lower price target is a fresh catalyst that can affect Amrize's stock and related sector peers.
What to watch
Potential upside from share buybacks and a stable debt profile could mitigate downside risk.
Background
BofA's downgrade follows its assessment of slower growth in U.S. cement, Canadian tariffs, and roofing market headwinds.
Market effects
Cement and building‑materials sector may face broader scrutiny as peers' valuations are reassessed.
North American construction materials markets could see modest pressure.
Limited to investors with exposure to Amrize and related material stocks.
Counterpoint
If Amrize can leverage its strong balance sheet for strategic acquisitions, the downgrade may be premature.
Key entities
- analystBank of America
Equity research firm issuing the downgrade.
- companyAmrize
Cement and building‑materials producer.
